FIELD: medicine, pharmacology. SUBSTANCE: the suggested rectal suppositories contain preparation of non-steroid group as indometacin and foundation at their following ratio of components, g/suppository: indometacin 0.05-0.1, aerosil 0.015, vitepsol W35 0.401 - 0.416, vitepsol H15 0.9360 0.9709, castor oil 0.039, urea 0.00105, nipasol 0.00045, twin-80 0.00750. The present innovation enables to provide high bioavailability of medicinal preparation at rectal way of its application, increases curative action of indometacin, improves its releasing out of medicinal form and its blood absorption, enables to obtain stable disperse system at applying low quantities of stabilizers by providing microbial purity of preparation at storage. EFFECT: higher efficiency. 2 ex, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
RECTAL SUPPOSITORIES WITH ANALGESIC ACTION | 2015 |
|
RU2607661C1 |
CALCIUM GLUCONATE NANOSUBSTANCE SUPPOSITORIES FOR TREATING DISEASES RELATED TO CALCIUM DEFICIENCY (VERSIONS) | 2012 |
|
RU2511649C1 |
RECTAL SUPPOSITORIES AND METHOD FOR PREPARATION THEREOF (OPTIONS) | 2017 |
|
RU2674029C1 |
RECTAL SUPPOSITORY MEDICINAL PRODUCT AND METHOD FOR ITS PREPARATION | 2018 |
|
RU2689320C1 |
SUPPOSITORIES FOR TREATMENT OF MODERATE AND HIGH-INTENSITY PAIN SYNDROME | 2019 |
|
RU2723960C1 |
PHARMACEUTICAL COMPOSITIONS BASED ON INDOMETHACIN MENTHYL ETHER AND THEIR APPLICATION AS ANTI-INFLAMMATORY AGENTS | 2017 |
|
RU2685257C1 |
COMPOSITION IN THE FORM OF RECTAL SUPPOSITORIES EXHIBITING ANALGESIC ACTIVITY | 2021 |
|
RU2786202C1 |
SUPPOSITORIES FOR TREATMENT OF MODERATE AND HIGH-INTENSITY PAIN SYNDROME | 2019 |
|
RU2723958C1 |
SUPPOSITORIES FOR TREATMENT OF MODERATE AND HIGH-INTENSITY PAIN SYNDROME | 2019 |
|
RU2723952C1 |
SUPPOSITORIES FOR TREATMENT OF MODERATE AND HIGH-INTENSITY PAIN SYNDROME | 2019 |
|
RU2723954C1 |
Authors
Dates
2004-03-27—Published
2002-08-27—Filed